{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:48:53Z","timestamp":1782380933796,"version":"3.54.5"},"reference-count":41,"publisher":"Informa UK Limited","issue":"12","funder":[{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","award":["261"],"award-info":[{"award-number":["261"]}],"id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Xenobiotica"],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.1080\/00498254.2021.2012727","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T10:11:15Z","timestamp":1638180675000},"page":"1372-1388","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Validation of population pharmacokinetic models: a comparison of internal and external validation approaches for hydrochlorothiazide"],"prefix":"10.1080","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9883-0381","authenticated-orcid":false,"given":"Rania","family":"Kousovista","sequence":"first","affiliation":[{"name":"Department of Mathematics and Applied Mathematics, University of Crete, Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Karali","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Applied Mathematics, University of Crete, Heraklion, Greece"},{"name":"Institute of Applied Mathematics and Computational Mathematics, Foundation of Research and Technology Hellas, Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Vlasopoulou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0492-0712","authenticated-orcid":false,"given":"Vangelis","family":"Karalis","sequence":"additional","affiliation":[{"name":"Institute of Applied Mathematics and Computational Mathematics, Foundation of Research and Technology Hellas, Heraklion, Greece"},{"name":"Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb04646.x"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1976195part1531"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746030-00003"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.5414\/CP202046"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2007.12.002"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1739"},{"key":"CIT0007","volume-title":"Pattern recognition: a statistical approach","author":"Devijver PA.","year":"1982"},{"key":"CIT0008","unstructured":"FDA 2020a. FDA approved drug products: Hydrochlorothiazide oral tablets; [accessed 2021 Nov 10]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/040735s004,040770s003lbl.pdf"},{"key":"CIT0009","unstructured":"FDA 2020b. FDA approved drug products: Microzide capsules. [accessed 2021 Nov 10]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/020504s018lbl.pdf"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4467-2"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1994.267.4.C869"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2010.191"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.059139"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1935"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2018.01.039"},{"key":"CIT0016","volume-title":"Hydrochlorothaizide","author":"Herman L","year":"2020"},{"key":"CIT0019","unstructured":"DrugBank 2020. Hydrochlorothiazide. [Updated 23 April 2020, Last accessed 10 Oct 2020]. https:\/\/www.drugbank.ca\/drugs\/DB00999"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13321"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100241"},{"key":"CIT0023","volume-title":"Clinical trial simulation and quantitative pharmacology: applications and trends","author":"Kimko HHC","year":"2010"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-014-9368-y"},{"key":"CIT0025","unstructured":"Kohavi R. 1995. A study of cross-validation and bootstrap for accuracy estimation and model selection. In: Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence. Morgan Kaufmann, San Mateo, p. 1137\u20131143."},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-005-0016-4"},{"issue":"6","key":"CIT0028","first-page":"570","volume":"17","author":"Meyer MC","year":"1975","journal-title":"Curr Ther Res Clin Exp"},{"key":"CIT0029","unstructured":"Mylan Pharmaceuticals 2020. Inc. Hydrochlorothiazide label. US Food & Drug Administration web site. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/040735s004,040770s003lbl.pdf. Revised May 2011. (Last accessed October 10, 2020)"},{"key":"CIT0030","volume-title":"The Merck Index - an encyclopedia of chemicals, drugs, and biologicals","author":"O\u2019Neil MJ.","year":"2001","edition":"13"},{"issue":"4","key":"CIT0031","first-page":"68","volume":"1","author":"Panneer SM","year":"2010","journal-title":"Int J Pharma Bio Sci"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1080\/00401706.1991.10484873"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005121329"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1977.1"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1007\/BF01060893"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1007\/BF03261932"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199937010-00003"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.01.009"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.05.013"},{"key":"CIT0040","unstructured":"US FDA 2020. Guidance for industry: population pharmacokinetics model [online]. Available from URL: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance\/documents\/population-pharmacokinetics. (Last accessed October 10,"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1863"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.04.013"},{"issue":"8","key":"CIT0043","first-page":"955","volume":"46","author":"Wei Y","year":"2011","journal-title":"Yao Xue Xue Bao"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2510070602"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666080-00006"}],"container-title":["Xenobiotica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00498254.2021.2012727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T14:04:43Z","timestamp":1645452283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00498254.2021.2012727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,2]]}},"alternative-id":["10.1080\/00498254.2021.2012727"],"URL":"https:\/\/doi.org\/10.1080\/00498254.2021.2012727","relation":{},"ISSN":["0049-8254","1366-5928"],"issn-type":[{"value":"0049-8254","type":"print"},{"value":"1366-5928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-10-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}